Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
4DMedical Ltd ( (AU:4DX) ) has shared an announcement.
4DMedical Limited has released its 2025 Corporate Governance Statement, detailing its adherence to the ASX Corporate Governance Council’s Principles and Recommendations. The company emphasizes its commitment to transparency and accountability by outlining its governance framework, which includes policies on anti-bribery, risk management, and diversity. This announcement reinforces 4DMedical’s dedication to maintaining high standards of corporate governance, which is crucial for its stakeholders, including shareholders, employees, and the community.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited operates in the healthcare industry, focusing on innovative medical imaging solutions. The company specializes in developing advanced respiratory imaging technology to enhance patient care and improve clinical outcomes.
Average Trading Volume: 6,156,309
Technical Sentiment Signal: Buy
Current Market Cap: A$767.5M
For a thorough assessment of 4DX stock, go to TipRanks’ Stock Analysis page.